bioavailability & bioequivalence

1. BIOAVAILABILITY -: Presented By :- Amruta S. Sambarekar 1st Year M.Pharm Dept. of Pharmaceutics M M C P, BELGAUM 1 2. CONTENTS Concept of Bioavailability Objectives…

1.  Absorptionis the process by which adrug enters the bloodstream without being chemically altered or  Theofmovement of a drug from its site applicationintolymphatic…

Slide 11 Introducing Pharmacokinetics and Pharmacodynamics Janice Davies Pharmacist Room 23 Maudland Building [email protected] Slide 2 eLearn 2 Slide 3 DVD Any problems…

Slide 1Sebastian Ueckert, Joakim Nyberg, Andrew C. Hooker Application of Quasi-Newton Algorithms in Optimal Design Pharmacometrics Research Group Department of Pharmaceutical…

Slide 1Evolving Science in Bioavailability and Bioequivalence Jim Wei, MD, PhD [email protected] ACPU, Cincinnati, OH, October 18-20, 2010 Slide 2 Agenda  Bioavailability/Bioequivalence…

Slide 1PK and PD as predictors of clinical effect Slide 2 2 PKPD workshop at AGAH/Club Phase I drug action – the interaction of the drug molecule at the binding site e.g.…

1. Site of Action Dosage Effects Plasma Concen. Pharmacokinetics Pharmacodynamics 2. Dose PlasmaConcentration 0 1 2 3 4 5 6 7 8 9 0 2 4 6 8 10 12 TOXIC RANGE THERAPEUTIC…

1. HERPES ZOSTER 2. HERPES ZOSTER (HZ) • An acute dermatomal infection associated with reactivation of VZV • Characterized by Unilateral pain • A vesicular or bullous…

1. Drug-Drug Interactions Dr. Najlaa Saadi Ismael Department of Pharmacology college of Medicine - Mosul University of Mosul 2. Drug – Drug interaction: It is the modification…